| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.019 | 0.7 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0099 | 0.7 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.7 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |